1. Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study. (October 2022) Authors: Wolf, J.; Garon, E.B.; Groen, H.J.M.; Tan, D.S.W.; Le Mouhaer, S.; Riester, M.; Ji, L.; Robeva, A.; Fairchild, L.; Boran, A.; Heist, R.S. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗